We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada Outlines Procedures Under New Drug Patent Regulations
Canada Outlines Procedures Under New Drug Patent Regulations
March 15, 2007
Health Canada has issued draft guidance on the administration of the amended Patented Medicines (Notice of Compliance) Regulations, which went into effect in October 2006 (IPRM, October 2006).
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor